NCT02839902View on ClinicalTrials.gov

Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 27, 2016

Primary Completion Date

August 30, 2017

Study Completion Date

August 30, 2017

Conditions
Hyperlipidemia
Interventions
DRUG

TAK-085

Omega-3-acid ethyl esters (TAK-085) capsule

OTHER

Not treated with omega-3-acid ethyl esters

Not treated with omega-3-acid ethyl esters

Trial Locations (7)

Unknown

Noda

Koga

Moriguchi

Suita

Fujimi

Mitaka

Saitama

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02839902 - Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood | Biotech Hunter | Biotech Hunter